Candice C. Poon
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 03, 2026
A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.
Journal: Journal of neuro-oncology
Published: October 17, 2025
The glymphatic system and glioblastoma.
Journal: Brain : a journal of neurology
Published: May 08, 2025
Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.
Journal: Journal of neurosurgery
Published: February 26, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome.
Journal: Cancer immunology research
Published: August 06, 2024
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade.
Journal: Nature cancer
Published: February 03, 2023
Immune checkpoint therapy-current perspectives and future directions.
Journal: Cell
Published: January 27, 2023
Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes.
Journal: Frontiers in immunology
Published: October 28, 2019
Control of brain tumor growth by reactivating myeloid cells with niacin.
Journal: Science translational medicine
Published: August 03, 2019
Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma.
Journal: Oncotarget
Published: January 11, 2019
Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
Journal: Scientific reports
Published: June 26, 2018
Last Updated: 09/26/2026